The delivery of TTN-AS1 through exosomes could provide a new avenue for cholangiocarcinoma therapy and offers experimental evidence for investigating the biological functions of exosomal LncRNA TTN-AS1 secreted by cholangiocarcinoma CTCs. Here, TTN is linked to cholangiocarcinoma.